Spironolactone and hydrochlorothiazide and Fainting - a phase IV clinical study of FDA data
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Spironolactone And Hydrochlorothiazide?
Spironolactone and hydrochlorothiazide has active ingredients of hydrochlorothiazide; spironolactone. It is used in swelling. Currently, eHealthMe is studying from 427 Spironolactone and hydrochlorothiazide users.
What is Fainting?
Fainting (loss of consciousness and postural tone) is found to be associated with 3,862 drugs and 3,435 conditions by eHealthMe. Currently, we are studying 126,076 people who have Fainting.
Do you take Spironolactone and hydrochlorothiazide and have Fainting?Check whether Fainting is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Spironolactone and hydrochlorothiazide side effects by duration, gender and age:
- Spironolactone and hydrochlorothiazide side effects (427 reports)
Fainting treatments and more:
- Fainting (126,076 reports)
All the drugs that are associated with Fainting:
All the conditions that are associated with Fainting:
How the study uses the data?
The study uses data from the FDA. It is based on hydrochlorothiazide; spironolactone (the active ingredients of Spironolactone and hydrochlorothiazide) and Spironolactone and hydrochlorothiazide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Rebif and Menstruation Irregular - 3 seconds ago
- Qutenza and Oxazepam drug interaction - 5 seconds ago
- Colace and Oxymetazoline Hydrochloride drug interaction - 6 seconds ago
- Myoview and Wellbutrin Xl drug interaction - 13 seconds ago
- Fosamax and Bursitis Infective - 21 seconds ago
- Avelox and Hyzaar drug interaction - 24 seconds ago
- Xanax and Oxygen Saturation Abnormal - 26 seconds ago
- Ondansetron and Myoglobinuria - 36 seconds ago
- Xalkori and Urinary Incontinence - 37 seconds ago
- Adderall and Tooth Abscess - 37 seconds ago